Topical antipsychotic composition

Details Topical antipsychotic composition Topical antipsychotic composition

2011-01-04

2011-01-04

Padmanabhan, Sreeni (Department: 1627)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S254040, C514S211130, C540S551000, C544S368000

Reexamination Certificate

active

07863277

ABSTRACT:
A transdermal composition that contains an antipsychotic is provided for the treatment of neuropsychiatric disorders. Also, provided are methods for preparing a topical antipsychotic composition. Methods for treating neuropsychiatric disorders, including schizophrenia, are further disclosed. The transdermal composition includes a therapeutically effective amount of an antipsychotic in an amount sufficient to treat neuropsychiatric disorders in a pharmaceutically acceptable carrier.

REFERENCES:
patent: 6290986 (2001-09-01), Murdock et al.
patent: 7666914 (2010-02-01), Richlin et al.
patent: 2002/0192300 (2002-12-01), Luo et al.
patent: 2003/0180352 (2003-09-01), Patel et al.
Yesook, Inclusion Complexation of Ziprasidone Mesylate with B-Cyclodextrin Sulfobutyl Ether, J. Pharm. Sci., Dec. 1998, vol. 87, No. 12, Publisher unknown.

Affiliated with

Also associated with

Rating

Topical antipsychotic composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Topical antipsychotic composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical antipsychotic composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2651999